Par Pharmaceuticals, Inc. drugs

1 result
  • dexmethylphenidate hydrochloride

    (Dexmethylphenidate Hydrochloride)
    Par Pharmaceuticals, Inc.
    Dexmethylphenidate Hydrochloride Extended-release Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).